Bill Anderson, Bayer's chief executive, updates investors on his turnaround plan for the German drugs and chemicals firm following its disastrous Monsanto acquisition.
When Alex Weprin, Editor, Digital News Daily, MediaPost, referred to Bayer as old, Joshua Palau, VP, Digital Strategy and Platforms, Bayer Consumer Health, told him just how old it is. His answer will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results